Chimeric Therapeutics Ltd (CHM) — Long-term Investment Intensity
Chimeric Therapeutics Ltd (CHM) has a Long-term Investment Intensity of 0.3% as of June 2024. Long-term investments of AU$40.00K represent 0.3% of total assets of AU$15.27 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Chimeric Therapeutics Ltd to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Chimeric Therapeutics Ltd Long-term Investment Intensity (2022–2024)
This chart shows how Chimeric Therapeutics Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of June 2024, the intensity stands at 0.3%, reflecting long-term investments of AU$40.00K against total assets of AU$15.27 Million AUD. For the complete balance sheet picture, see total assets of Chimeric Therapeutics Ltd.
Annual Long-term Investment Intensity for Chimeric Therapeutics Ltd (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Chimeric Therapeutics Ltd from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CHM total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.3% | AU$40.00K | AU$15.27 Million | ▲ +0.1 pp |
| 2023 | 0.2% | AU$40.00K | AU$22.38 Million | ▲ +0.1 pp |
| 2022 | 0.1% | AU$40.00K | AU$34.88 Million | — |